Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
LONGER Launches Ray5 miniS Enclosed Laser Engraver with FDA Class 1 Safety Certification
Via AB Newswire
Tickers AMZN
Exposures Product Safety
News headline image
Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse
Via TokenRing AI
Topics Artificial Intelligence
Tickers AAPL ASX:RMD FIT GOOGL RMD
Exposures Artificial Intelligence Product Safety
News headline image
The Digital Microscope: How AlphaFold 3 is Decoding the Molecular Language of Life
Via TokenRing AI
Topics Artificial Intelligence Bonds
Tickers GOOGL LLY META NVDA NVS TMO
Exposures Artificial Intelligence Debt Markets Product Safety
News headline image
Atara&#39;s Outlook As Ebvallo Hits Second FDA CRL ↗
Via Benzinga
Exposures Product Safety
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval ↗
Via Stocktwits
Tickers IBB IBRX IWM VBK XBI
Exposures Product Safety
News headline image
FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel
Via MarketMinute
Topics Bankruptcy
Tickers ATRA JNJ TVGN
Exposures Financial Legal Product Safety
News headline image
High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
Via PRLog
Exposures Product Safety
News headline image
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout ↗
Via Stocktwits
Tickers COPJ NVS SLS VTI
Exposures Product Safety
News headline image
Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
Via MarketMinute
Topics Earnings Economy
Tickers BRK-A BRK-B COR HUM LLY NVO
Exposures Financial Interest Rates Product Safety
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings ↗
Via Stocktwits
Tickers LLY LLYX NVO NVOX
Exposures Product Safety
News headline image
Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis
Via Finterra
Topics Artificial Intelligence World Trade
Tickers GEHC MDT MMM NVST ORCL SOLV
Exposures Artificial Intelligence Product Safety Tariff
News headline image
Viatris Inc. (NASDAQ: VTRS): Navigating the Pivot from Integration to Innovation
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers BLK NVS PFE TEVA VTRS
Exposures Financial Intellectual Property Interest Rates
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
News headline image
Moderna’s High-Stakes Transformation: Navigating the Post-Pandemic Pivot
Via Finterra
Topics Initial Public Offering Intellectual Property
Tickers ABUS BNTX GSK JPM MRK MRNA
Exposures COVID-19 Intellectual Property Product Safety
News headline image
BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without Bupropion
Via NewMediaWire
Tickers BICX
Exposures Product Safety
BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without Bupropion
Via TheNewswire.com
Exposures Product Safety
News headline image
Axogen CEO Axed 25,000 Shares From His Direct Holdings ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers AXGN
Exposures Legal Product Safety Regulatory
News headline image
OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
Travere Stock Slips After FDA Delays Review Of Key Kidney Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
The Naming Decision: Why Early-Stage Founders Spend Weeks on What Seems Like a Simple Choice
Via GlobePRwire
Topics Economy Product Recall
Exposures Economy Legal Product Safety
News headline image
Why Travere Therapeutics Stock Got Trounced on Tuesday ↗
Via The Motley Fool
Tickers TVTX
Exposures Product Safety
News headline image
Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS
Via MarketMinute
Tickers NVS TVTX VRTX
Exposures Product Safety
News headline image
Traditional Egyptian Roasting Methods Define Unique Chocolate Experience from JP John Paul
Via AB Newswire
Exposures Product Safety
News headline image
Sisi Hollywood Opens 2026 with an Intimate Season Premiere Featuring Legendary Composer Randy Edelman at Mandarin Oriental New York
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Anthropic Unveils Specialized ‘Claude for Healthcare’ and ‘Lifesciences’ Suites with Native PubMed and CMS Integration
Via TokenRing AI
Topics Artificial Intelligence
Tickers AAPL AMZN GOOGL JPM MSFT
Exposures Artificial Intelligence Product Safety
News headline image
Travere Therapeutics Stock Slumps After FDA Extends Drug Review Timeline To April ↗
Via Stocktwits
Tickers TVTX
Exposures Product Safety
News headline image
FDA Says No Clear Link Found Between Popular Weight Loss Drugs And Suicidal Thoughts, Review Ongoing ↗
Via Benzinga
Exposures Product Safety
News headline image
AGIG Stock Up Nearly 30% - What Triggered The Rally Today? ↗
Via Stocktwits
Tickers AGIG IAK KBWP PKW
Exposures Product Safety
Language Scientific Examines Common Risks in Pharmaceutical Marketing Translation
Via Press Advantage
Exposures Product Safety
Language Scientific Outlines What “Quality” Means in Medical Device Labeling Translation
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.